Blobe GC - Search Results

1

Loss of type III transforming growth factor-beta receptor expression is due to methylation silencing of the transcription factor GATA3 in renal cell carcinoma.

Cooper SJ, Zou H, Legrand SN, Marlow LA, von Roemeling CA, Radisky DC, Wu KJ, Hempel N, Margulis V, Tun HW, Blobe GC, Wood CG, Copland JA. Cooper SJ, et al. Among authors: blobe gc. Oncogene. 2010 May 20;29(20):2905-15. doi: 10.1038/onc.2010.64. Epub 2010 Mar 8. Oncogene. 2010. PMID: 20208565 Free PMC article.

2

Expression of the type III TGF-beta receptor is negatively regulated by TGF-beta.

Hempel N, How T, Cooper SJ, Green TR, Dong M, Copland JA, Wood CG, Blobe GC. Hempel N, et al. Among authors: blobe gc. Carcinogenesis. 2008 May;29(5):905-12. doi: 10.1093/carcin/bgn049. Epub 2008 Feb 24. Carcinogenesis. 2008. PMID: 18299279 Free PMC article.

3

The type III TGF-beta receptor suppresses breast cancer progression through GIPC-mediated inhibition of TGF-beta signaling.

Lee JD, Hempel N, Lee NY, Blobe GC. Lee JD, et al. Among authors: blobe gc. Carcinogenesis. 2010 Feb;31(2):175-83. doi: 10.1093/carcin/bgp271. Epub 2009 Dec 2. Carcinogenesis. 2010. PMID: 19955393 Free PMC article.

4

The type III transforming growth factor-beta receptor as a novel tumor suppressor gene in prostate cancer.

Turley RS, Finger EC, Hempel N, How T, Fields TA, Blobe GC. Turley RS, et al. Among authors: blobe gc. Cancer Res. 2007 Feb 1;67(3):1090-8. doi: 10.1158/0008-5472.CAN-06-3117. Cancer Res. 2007. PMID: 17283142

5

The type III TGF-beta receptor suppresses breast cancer progression.

Dong M, How T, Kirkbride KC, Gordon KJ, Lee JD, Hempel N, Kelly P, Moeller BJ, Marks JR, Blobe GC. Dong M, et al. Among authors: blobe gc. J Clin Invest. 2007 Jan;117(1):206-17. doi: 10.1172/JCI29293. Epub 2006 Dec 7. J Clin Invest. 2007. PMID: 17160136 Free PMC article.

6

Loss of betaglycan expression in ovarian cancer: role in motility and invasion.

Hempel N, How T, Dong M, Murphy SK, Fields TA, Blobe GC. Hempel N, et al. Among authors: blobe gc. Cancer Res. 2007 Jun 1;67(11):5231-8. doi: 10.1158/0008-5472.CAN-07-0035. Epub 2007 May 23. Cancer Res. 2007. PMID: 17522389

7

Fibulin-3 is a novel TGF-β pathway inhibitor in the breast cancer microenvironment.

Tian H, Liu J, Chen J, Gatza ML, Blobe GC. Tian H, et al. Among authors: blobe gc. Oncogene. 2015 Nov 5;34(45):5635-47. doi: 10.1038/onc.2015.13. Epub 2015 Mar 30. Oncogene. 2015. PMID: 25823021 Free PMC article.

8

Loss of type III transforming growth factor beta receptor expression increases motility and invasiveness associated with epithelial to mesenchymal transition during pancreatic cancer progression.

Gordon KJ, Dong M, Chislock EM, Fields TA, Blobe GC. Gordon KJ, et al. Among authors: blobe gc. Carcinogenesis. 2008 Feb;29(2):252-62. doi: 10.1093/carcin/bgm249. Epub 2007 Nov 13. Carcinogenesis. 2008. PMID: 17999987

9

Increased type III TGF-β receptor shedding decreases tumorigenesis through induction of epithelial-to-mesenchymal transition.

Huang JJ, Corona AL, Dunn BP, Cai EM, Prakken JN, Blobe GC. Huang JJ, et al. Among authors: blobe gc. Oncogene. 2019 May;38(18):3402-3414. doi: 10.1038/s41388-018-0672-7. Epub 2019 Jan 14. Oncogene. 2019. PMID: 30643193 Free PMC article.

10

Bone morphogenetic proteins signal through the transforming growth factor-beta type III receptor.

Kirkbride KC, Townsend TA, Bruinsma MW, Barnett JV, Blobe GC. Kirkbride KC, et al. Among authors: blobe gc. J Biol Chem. 2008 Mar 21;283(12):7628-37. doi: 10.1074/jbc.M704883200. Epub 2008 Jan 9. J Biol Chem. 2008. PMID: 18184661 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

108 results

Search Page

Filters